The median ( IQR ) first - and second-phase insulin secretion responses increased significantly by 56.3 % ( 45.2-112 .6 % , P = 0.005 ) and 39.3 % ( 26.5-81 .0 % , P = 0.006 ) , respectively , following sitagliptin treatment as compared with no sitagliptin treatment .